Martini Jeffrey S Insider Trading -- Recent SEC Form 4 Transactions
Martini Jeffrey S (CIK 1914560) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-12). Recent activity: Sell PVLA (1,467 shares), Buy PVLA (1,984 shares), Sell PVLA (100 shares), Sell PVLA (1,449 shares), Sell PVLA (1,651 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,467 | $243,196 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Buy | 1,984 | $19,423 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 100 | $16,334 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,449 | $238,871 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,651 | $273,814 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,500 | $250,369 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 200 | $33,562 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 550 | $92,965 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 800 | $137,695 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Buy | 6,250 | $61,187 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,650 | $270,835 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Buy | 4,266 | $32,123 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,133 | $188,942 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 1,200 | $201,299 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 600 | $101,240 |
| 2026-11-12 | PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Scientific Officer | Sell | 200 | $33,956 |
Source: SEC Form 4 filings · as of 2026-11-12